Free Light Chains & Monoclonal Gammopathies

In this presentation:

With the introduction of Mayo’s expanded serum monoclonal protein panel, which includes quantitation of the kappa and lambda free light chains, urine monoclonal protein studies are no longer required as part of the initial diagnostic screen for monoclonal gammopathies.

Jerry Katzmann, PhD, from the Division of Clinical Biochemistry and Immunology at Mayo Clinic, discusses Mayo’s approach to the diagnosis of monoclonal gammopathies and the use of serum free light chain assays.

View the presentationSend to a colleague

Upon viewing the video, you may obtain a Record of Viewing.

Preferred serum screening test:

• #87997 Monoclonal Protein Study, Expanded Panel, Serum (includes kappa and lambda free light chains)

Related tests:

• #84190 Immunoglobulin Free Light Chains, Serum
• #81756 Monoclonal Protein Study, Serum
• #8823 Monoclonal Protein Study, Urine

Related Information

• Learn more about Dr. Jerry Katzmann
• Learn more about the Division of Clinical Biochemistry and Immunology